Search results
Your search for Supportan returned no results
Showing 556 to 570 of 675 results for supporting
Showing 556 to 570 of 675 results for supporting
Our landmark review demonstrates a new approach to keeping NHS care up-to-date and could benefit thousands of adults with metastatic prostate cancer.
Appraisal is the process of determining which records have continuing business or historical value from those which have no further value and should be disposed of appropriately.
This document describes a real-world evidence framework that aims to improve the quality of real-world evidence informing our guidance. The framework does not set minimum standards for the acceptability of evidence. The framework is mainly targeted at those developing evidence to inform NICE guidance. It is also relevant to patients, those collecting data, and reviewers of evidence
The appeal panel is drawn from a group of people approved by the Secretary of State for Health and Social Care to hear appeals.
Clarification on demonstrating patient access to medicines and treatments recommended by NICE Technology Appraisal (TA) or Highly Specialised Technologies (HST) guidance.
This guideline covers the care of pregnant women and pregnant trans and non-binary people and their babies during labour and immediately after birth. It focuses on women and pregnant people who give birth between 37 and 42 weeks of pregnancy (‘term’). The guideline helps women and pregnant people to make informed choices about where to have their baby and about their care in labour. It also aims to reduce variation in aspects of care.
View recommendations for NG235Show all sections
Sections for NG235
- Overview
- Recommendations
- Recommendations for research
- Rationale and impact
- Context
- Appendix A: Adverse outcomes for different places of birth
- Appendix B: Outcomes for different places of birth – by BMI at booking
- Appendix C: Outcomes for intravenous remifentanil patient-controlled analgesia (PCA) compared with intramuscular pethidine
Our quality standards set out priority areas for quality improvement in health, public health and social care.
Past technology appraisal appeals and decisions
Technology appraisal and highly specialised technologies appeals
Learn about the NICE Technology Appraisal and Highly Specialised Technologies appeals process, including how decisions are made, the criteria for appeals, and the role of the appeal panel in ensuring fair and transparent evaluations of health technologies.
Find out more about the NICE technology appraisal advisory committee B members and their registered interests
First HIV prevention injection for people unable to have daily PrEP recommended
A ground-breaking HIV-1 prevention injection has been recommended by NICE, marking a significant advance for a small group of adults and young people unable to have daily pre-exposure prophylaxis (PrEP) tablets.
inform conversations between a person and their healthcare professional, supporting them to make informed choices in line with their...
Data on the recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
Biographies and registered interests for members of the Technology Appraisal Committee A
Data on the cancer recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.